| Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
|
|---|
| Outline of Final Research Achievements |
Bone morphogenic proteins (BMPs) is reported that the most effective factor for promoting proliferation and differentiation for osteoblast when assuming bone regeneration therapy. However, it has been clarified that BMP is not expected a satisfactory bone formation reaction, because of inflammatory reaction with surgical treatment in vivo.
Therefore, we attempt to establish novel bone regeneration therapy utilizing combination of multiple growth factors which having an acting mechanism different from BMP signal pathway.
|
